BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 70 filers reported holding BIODELIVERY SCIENCES INTL IN in Q2 2018. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $739,000 | -23.2% | 238,399 | -10.5% | 0.00% | – |
| Q3 2021 | $962,000 | +201.6% | 266,460 | +199.6% | 0.00% | – |
| Q2 2021 | $319,000 | -54.1% | 88,946 | -49.9% | 0.00% | – |
| Q1 2021 | $695,000 | +126.4% | 177,628 | +143.4% | 0.00% | – |
| Q4 2020 | $307,000 | -32.2% | 72,988 | -40.0% | 0.00% | – |
| Q3 2020 | $453,000 | +90.3% | 121,684 | +122.7% | 0.00% | – |
| Q2 2020 | $238,000 | -4.8% | 54,648 | -17.1% | 0.00% | – |
| Q1 2020 | $250,000 | -35.6% | 65,893 | +7.5% | 0.00% | – |
| Q4 2019 | $388,000 | +300.0% | 61,310 | +167.5% | 0.00% | – |
| Q3 2019 | $97,000 | -5.8% | 22,920 | +3.6% | 0.00% | – |
| Q2 2019 | $103,000 | -18.3% | 22,126 | -6.8% | 0.00% | – |
| Q1 2019 | $126,000 | – | 23,748 | +19690.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 120 | -98.3% | 0.00% | – |
| Q3 2018 | $20,000 | – | 7,077 | +4849.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 143 | -86.2% | 0.00% | – |
| Q1 2018 | $2,000 | – | 1,037 | +764.2% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 120 | -94.3% | 0.00% | – |
| Q3 2017 | $6,000 | – | 2,110 | +1643.8% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 121 | -92.0% | 0.00% | – |
| Q1 2017 | $3,000 | 0.0% | 1,520 | 0.0% | 0.00% | – |
| Q4 2016 | $3,000 | +200.0% | 1,520 | +192.3% | 0.00% | – |
| Q3 2016 | $1,000 | -96.8% | 520 | -96.0% | 0.00% | – |
| Q2 2016 | $31,000 | – | 13,152 | +65660.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 20 | -99.8% | 0.00% | – |
| Q4 2015 | $62,000 | +933.3% | 12,885 | +1102.0% | 0.00% | – |
| Q3 2015 | $6,000 | -89.7% | 1,072 | -85.2% | 0.00% | – |
| Q2 2015 | $58,000 | +1060.0% | 7,257 | +1484.5% | 0.00% | – |
| Q1 2015 | $5,000 | -90.0% | 458 | -88.9% | 0.00% | – |
| Q4 2014 | $50,000 | -83.9% | 4,124 | -77.2% | 0.00% | – |
| Q3 2014 | $310,000 | +105.3% | 18,124 | +45.0% | 0.00% | – |
| Q2 2014 | $151,000 | -53.7% | 12,500 | -67.6% | 0.00% | – |
| Q1 2014 | $326,000 | +183.5% | 38,589 | +97.0% | 0.00% | – |
| Q4 2013 | $115,000 | +130.0% | 19,585 | +114.2% | 0.00% | – |
| Q3 2013 | $50,000 | +257.1% | 9,143 | +163.6% | 0.00% | – |
| Q2 2013 | $14,000 | – | 3,469 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,575,000 | $6,615,000 | 4.38% |
| 1492 Capital Management LLC | 790,863 | $3,322,000 | 1.91% |
| Rubric Capital Management LP | 3,516,124 | $14,768,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $40,026,000 | 0.79% |
| Zebra Capital Management LLC | 144,241 | $606,000 | 0.77% |
| KNOTT DAVID M | 370,230 | $1,555,000 | 0.70% |
| Nantahala Capital Management | 5,123,671 | $21,519,000 | 0.67% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,593,893 | $15,094,000 | 0.66% |
| EMC Capital Management | 98,933 | $416,000 | 0.32% |
| ALGERT GLOBAL LLC | 175,170 | $736,000 | 0.21% |